Patents by Inventor Charles S. T. Hii

Charles S. T. Hii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying agents that selectively activate p38 and/or NKkB signaling
    Patent number: 8268635
    Abstract: The present invention relates to a method of selectively modulating a signalling pathway of interest controlled by a cell receptor involved in signalling through multiple pathways. The method includes exposing the receptor to an agent that modulates signalling by the receptor through the signalling pathway of interest and does not substantially modulate signalling through one or more other signalling pathways controlled by the receptor.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: September 18, 2012
    Inventors: Antonio Ferrante, Charles S. T. Hii
  • MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION
    Publication number: 20100104546
    Abstract: The present invention relates to a method of inhibiting antigen-dependent proliferation of T-cells in a subject without substantially inhibiting mitogen-dependent proliferation of T-cells in the subject. The method includes administering to the subject an effective amount of a polyunsaturated fatty acid, or a salt or derivative of a polyunsaturated fatty acid.
    Type: Application
    Filed: February 5, 2008
    Publication date: April 29, 2010
    Applicant: CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE
    Inventors: Antonio Ferrante, Nick Gorgani, Charles S.T. Hii
  • Selective Modulation of Receptor Signalling
    Publication number: 20090291899
    Abstract: The present invention relates to a method of selectively modulating a signalling pathway of interest controlled by a cell receptor involved in signalling through multiple signalling pathways The method includes exposing the receptor to an agent that modulates signalling by the receptor through the signalling pathway of interest and does not substantially modulate signalling through one or more other signalling pathways controlled by the receptor.
    Type: Application
    Filed: May 18, 2007
    Publication date: November 26, 2009
    Inventors: Antonio Ferrante, Charles S.T. Hii